Treprostinil CALLED LRX 15; Rumodolin; U-62840 CAS NUMBER 81846-19-7

Basic Info

Model No.: 81846-19-7

Additional Info

Packaging: As required

Productivity: Commercial

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Certificate: Technical Support

Product Description

Treprostinil cas number 81846-19-7 is a targeted drug for the treatment of pulmonary hypertension. It promotes pulmonary vasodilation, inhibits platelet aggregation and thrombosis, stimulates thrombolysis, inhibits pulmonary vascular remodeling, and thereby reduces pulmonary artery pressure and pulmonary vascular resistance.It has a significant effect on high pressure. It is obtained from prostacyclin by replacing the alkenyl ether with a functional group of a phenol ether. Precursor has excellent stability, with a half-life of 4 hours in the circulation, no decomposition at 25 degrees C for five years, and no decomposition of the drug as it passes through the lungs. At the same time,Treprostinil  cas number 81846-19-7 has good biological activity and has good curative effect in the treatment of pulmonary hypertension, peripheral vascular disease, ischemic disease, treatment of improving renal function, neuropathic foot ulcer, asthma and even treatment of cancer. In particular, in the treatment of pulmonary hypertension, Remodulin, a new drug containing the sodium salt of Treprostinil, was approved for marketing in 2004.

Thera. Category:  Anti- pulmonary hypertension

Cas No.:81846-19-7

Synonyms: Acetic acid,( 56985586,(2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-(3-hydroxyoctyl)-1H-benz(f)inden-5-yl)oxy)-,( 56985587,1R-(1alpha(S*),2beta,3aalpha,9aalpha))-;Acetic acid,[[(1R,2R,3aS,9aS)-2,3,3a,4,9,9ahexahydro- 2-hydroxy-1-[(3S)-3-hydroxyoctyl]- 1H-benz[f]inden-5-yl]oxy]-;U 62840;LRX 15;Treprostinil [USAN:INN];Remodulin;289480-64-4;15AU81;

NW: 390.5131

M.W.:C23H34O5

Assay: ≥99%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request